Juha Näpänkangas
- Co-authors
- Kari YlitaloIlmo E. HassinenJukka MönkkönenAlex AzhayevH. Kalervo VäänänenPetri LehenkariMichael J. RogersJaana Rysä
- Topics
- Cardiac Valve Diseases and Treatments (7 papers)Cardiac Fibrosis and Remodeling (7 papers)Cardiovascular Function and Risk Factors (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaApplied Physics LettersPLoS ONE
- Partner nations
- FinlandUnited KingdomSweden
In The Last Decade
Juha Näpänkangas
35 papers receiving 990 citations
Peers
Comparison fields: 5 of 109
- Oncology 367
- Molecular Biology 305
- Cardiology and Cardiovascular Medicine 208
- Immunology 135
- Surgery 133
Countries citing papers authored by Juha Näpänkangas
This map shows the geographic impact of Juha Näpänkangas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juha Näpänkangas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juha Näpänkangas more than expected).
Fields of papers citing papers by Juha Näpänkangas
This network shows the impact of papers produced by Juha Näpänkangas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juha Näpänkangas. The network helps show where Juha Näpänkangas may publish in the future.
Co-authorship network of co-authors of Juha Näpänkangas
This figure shows the co-authorship network connecting the top 25 collaborators of Juha Näpänkangas. A scholar is included among the top collaborators of Juha Näpänkangas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juha Näpänkangas. Juha Näpänkangas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 13 | |
| 3 | 21 | |
| 4 | 9 | |
| 5 | 43 | |
| 6 | 25 | |
| 7 | 7 | |
| 8 | 15 | |
| 9 | 3 | |
| 10 | 55 | |
| 11 | 22 | |
| 12 | 200 | |
| 13 | 42 | |
| 14 | Statin treatment and gene expression of anti-atherogenic factor C-type natriuretic peptide system in stenotic aortic valves. | 3 |
| 15 | 32 | |
| 16 | 29 | |
| 17 | 19 | |
| 18 | 28 | |
| 19 | 36 | |
| 20 | 264 |
About Juha Näpänkangas
Juha Näpänkangas is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Oncology, having authored 35 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (7 papers), Cardiac Fibrosis and Remodeling (7 papers) and Cardiovascular Function and Risk Factors (4 papers). The work is most often cited by research in Oncology (367 citations), Orthopedics and Sports Medicine (89 citations) and Cardiology and Cardiovascular Medicine (208 citations). Juha Näpänkangas has collaborated with scholars based in Finland, United Kingdom and Sweden. Frequent co-authors include Kari Ylitalo, Ilmo E. Hassinen, Jukka Mönkkönen, Alex Azhayev, H. Kalervo Väänänen, Petri Lehenkari, Michael J. Rogers, Jaana Rysä, Heikki Ruskoaho and Markus J. Mäkinen. Their work appears in journals such as SHILAP Revista de lepidopterología, Applied Physics Letters and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.